-
Cysec, one of the 5 winners of the Swisscom Startup Challenge
21.09.202121.9.2021 – One of the 5 winners of the Swisscom Startup Challenge is the company Cysec. Based at the...
-
New $135M Fund for Early-Stage Investments in European Digital Tech Startups
17.09.202117.9.2021 – Venture capital firm btov Partners announces the final closing of its new digital technologies early-stage fund with a...
-
Venture Competition 2021: here are the winners
14.09.202114.9.2021 – The >> Venture Award Ceremony took place last night (13.9.2021) in Zurich! A fantastic occasion to celebrate...
-
LIGENTEC and X-FAB collaboration creates Europe’s largest capacity foundry service for integrated photonic circuits
14.09.202114.9.2021 – LIGENTEC, based at EPFL Innovation Park, pioneer in high-performance, low-loss, silicon nitride photonic solutions, and specialty semiconductor...
-
Inpher Secures Strategic Investment from Swisscom Ventures
10.09.202109.9.2021 – Inpher, the cryptogtraphic Secret Computing pioneer, announces a strategic investment from Swisscom Ventures to fuel growth and...
-
The TOP 100 Swiss Startup Award 2021 – discover the most promising startups in Switzerland
09.09.202111.9.2021 – The 11th edition of the TOP 100 Swiss Startup Award celebrated Switzerland’s best startups: Planted Foods (1st),...
-
Ten technology startups prepare for Silicon Valley trip
02.09.202102.9.2021 – An expert jury selected ten startups ready to grow internationally and expand their networks and expertise during the...
-
Swisscom Startup Challenge finalists revealed
02.09.20212.9.2021 – The latest finalist selection for Swisscom Startup Challenge 2021 focusing on cybersecurity includes 10 start-ups, of which...
-
HemostOD raises CHF 1.7M in seed round financing
02.09.202102.9.2021 – HemostOD SA, based at EPFL Innovation Park, Swiss leader in the production of on-demand, immune-neutral platelets, announces...
-
AC Immune’s antibody shows therapeutic effect in Alzheimer’s patients
31.08.202131.8.2021 – Top-line data from Lauriet Phase 2 trial of semorinemab in mild-to-moderate Alzheimer’s Disease shows a statistically significant...
News
EPFL Innovation Park - > News
